The Patent Loophole Saving Lives
June 23, 2026 1:13 PM
Patent Loophole Brings Life-Saving Cystic Fibrosis Drug to Patients Who Can’t Afford It
A powerful story about how a patent law loophole in Bangladesh gave cystic fibrosis patients access to a life-saving drug that costs $346,000 a year in the United States, raising important questions about innovation, patents, and healthcare access.
(8)
Tags: Bangladesh pharmaceuticals, Beximco Pharmaceuticals, cystic fibrosis, drug pricing, generic drugs, Global health, healthcare access, healthcare inequality, innovation and ethics, INTELLECTUAL PROPERTY, Invention and Innovation, life-saving drugs, medical breakthroughs, medical innovation, medicine affordability, patent law, pharmaceutical patents, Trikafta, Triko, Vertex Pharmaceuticals
